Comparison
3 Beta Hydroxysteroid Dehydrogenase Deficiency C0342471 vs 17q12 Recurrent Deletion Syndrome C6011081
Clinical comparison between 3 Beta Hydroxysteroid Dehydrogenase Deficiency and 17q12 Recurrent Deletion Syndrome for differential diagnosis and treatment planning.
3 Beta Hydroxysteroid Dehydrogenase Deficiency C0342471
A rare genetic disorder affecting adrenal hormone production. It can cause ambiguous genitalia, salt-wasting crises, and hormonal imbalances. Treatment requires hormone replacement therapy and careful monitoring.
17q12 Recurrent Deletion Syndrome C6011081
A genetic condition from deletion on chromosome 17. Can involve developmental delays, neurological features, and potential kidney involvement. Management requires regular monitoring and supportive therapies.
6 comparison axes
Onset
3 Beta Hydroxysteroid Dehydrogenase Deficiency C0342471
0-null
17q12 Recurrent Deletion Syndrome C6011081
0-null
Onset patterns differ
Severity
3 Beta Hydroxysteroid Dehydrogenase Deficiency C0342471
severe
17q12 Recurrent Deletion Syndrome C6011081
moderate
Different severity levels
Chronic
3 Beta Hydroxysteroid Dehydrogenase Deficiency C0342471
Chronic
17q12 Recurrent Deletion Syndrome C6011081
Chronic
Differing course
Communicable
3 Beta Hydroxysteroid Dehydrogenase Deficiency C0342471
No
17q12 Recurrent Deletion Syndrome C6011081
No
Different transmission
Body System
3 Beta Hydroxysteroid Dehydrogenase Deficiency C0342471
endocrine
17q12 Recurrent Deletion Syndrome C6011081
congenital
Same/different system
Category
3 Beta Hydroxysteroid Dehydrogenase Deficiency C0342471
endocrine
17q12 Recurrent Deletion Syndrome C6011081
genetic
Different category
Bottom line
3-beta-hydroxysteroid-dehydrogenase-deficiency-C0342471 and 17q12-recurrent-deletion-syndrome-C6011081 differ in severity, etiology
Key differentiating points
Findings that most reliably separate the two conditions at the bedside or in the workup.
| Feature | 3 Beta Hydroxysteroid Dehydrogenase Deficiency C0342471 | 17q12 Recurrent Deletion Syndrome C6011081 | Discriminating power |
|---|---|---|---|
| Genital and sex-development findings | Ambiguous genitalia or disordered sex development may occur from impaired steroidogenesis. | Genital ambiguity is not a defining feature in the supplied description. | Moderate |
| Salt-wasting or adrenal crisis | Salt-wasting crisis and hormonal imbalance are recognized possible presentations. | Adrenal crisis is not established as a characteristic feature. | High |
| Developmental and renal features | Neurodevelopmental delay or kidney disease is not the primary described pattern. | Developmental delay, neurologic features, and possible kidney involvement may occur. | Moderate |
When to favor each condition
Choose 3 Beta Hydroxysteroid Dehydrogenase Deficiency C0342471 when
Infant with suspected adrenal insufficiency
Salt-wasting and steroid hormone imbalance point toward an adrenal steroidogenic disorder.
High
Disordered sex development with endocrine clues
Ambiguous genitalia plus adrenal findings support specialist endocrine evaluation.
Moderate
Abnormal steroid profile needing confirmation
An abnormal result is not itself a diagnosis and requires clinician interpretation.
High
Choose 17q12 Recurrent Deletion Syndrome C6011081 when
Developmental delay with congenital anomalies
The supplied pattern emphasizes developmental, neurologic, and possible renal involvement.
Moderate
Suspected chromosomal deletion
A recurrent 17q12 deletion is a genetic diagnosis requiring appropriate testing.
High
Kidney concern without adrenal crisis
Renal monitoring may be relevant, but kidney findings alone do not establish the syndrome.
Low
How key tests differ
| Test | 3 Beta Hydroxysteroid Dehydrogenase Deficiency C0342471 | 17q12 Recurrent Deletion Syndrome C6011081 | Interpretation |
|---|---|---|---|
| Steroid hormone evaluation | May show adrenal steroid imbalance; exact cutoffs are not supplied. | No characteristic steroid pattern is established here. | Interpret only with clinical context and specialist review. |
| Chromosomal microarray or deletion testing | Not the primary test suggested by the supplied endocrine description. | Can identify a recurrent 17q12 deletion when clinically indicated. | Genetic confirmation should be directed by a clinician or geneticist. |
| Electrolytes and renal assessment | Electrolyte disturbance may accompany salt-wasting; thresholds are not specified. | Renal evaluation may be considered because kidney involvement is possible. | Abnormal results require clinical correlation and do not alone confirm either condition. |
Prognosis comparison
3 Beta Hydroxysteroid Dehydrogenase Deficiency C0342471
- Outcome
- Potentially severe but may be manageable with hormone replacement and monitoring; exact outcomes are not established here.
- Factors
- Crisis recognition, endocrine care, and treatment adherence are important, though quantitative effects are unavailable.
17q12 Recurrent Deletion Syndrome C6011081
- Outcome
- Often described as moderate, with variable developmental, neurologic, and possible renal effects.
- Factors
- Supportive therapies and regular monitoring influence care needs; prognosis is not uniform.
Time frame: Both are chronic; onset data are incomplete.
Individual genetics, complications, and access to specialist care affect course.
Complications comparison
| Complication | Presentation |
|---|---|
| Acute decompensation | Salt-wasting crisis is a potentially severe complication. Acute adrenal crisis is not established from the supplied data. Urgent care is needed for suspected crisis; exact risk is not quantified here. |
| Developmental impact | Not described as the main complication. Developmental delay and neurologic features may require support. Severity and outcome vary and are not fully established. |
| Organ involvement | Adrenal hormone deficiency is central. Possible kidney involvement warrants monitoring. Neither finding should be assumed in every patient. |
Patient education highlights
- HighEmergency symptoms
Seek urgent care for vomiting, dehydration, lethargy, or suspected salt-wasting crisis, especially in the enzyme deficiency.
- MediumMonitoring
Hormone replacement and monitoring may be needed for the enzyme disorder; developmental and renal follow-up may be relevant for the deletion syndrome.
- LowInheritance and testing
Both are genetic conditions, but testing, recurrence risk, and counseling should be individualized by specialists.